Cargando…
Current Challenges for HER2 Testing in Diagnostic Pathology: State of the Art and Controversial Issues
HER2 overexpression and anti-HER2 agents represent probably the best story of success of individualized therapy in breast cancer. Due to the important therapeutic implications, the issue under the spotlight has been, since ever, the correct identification of true HER2 positivity on tissue specimens....
Autores principales: | Sapino, Anna, Goia, Margherita, Recupero, Daniele, Marchiò, Caterina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659312/ https://www.ncbi.nlm.nih.gov/pubmed/23734345 http://dx.doi.org/10.3389/fonc.2013.00129 |
Ejemplares similares
-
Cold Formalin Fixation Guarantees DNA Integrity in Formalin Fixed Paraffin Embedded Tissues: Premises for a Better Quality of Diagnostic and Experimental Pathology With a Specific Impact on Breast Cancer
por: Berrino, Enrico, et al.
Publicado: (2020) -
Gliomatosis Cerebri: Current Understanding and Controversies
por: Ranjan, Surabhi, et al.
Publicado: (2017) -
Controversial topics in metastatic HR+/HER2- breast cancer: Guiding treatment by a modified Delphi approach
por: Fabi, Alessandra, et al.
Publicado: (2022) -
Malnutrition management in oncology: An expert view on controversial issues and future perspectives
por: Bossi, Paolo, et al.
Publicado: (2022) -
Current Controversies and the State of the Art in Endovascular Treatment of Vascular Malformations
por: Yakes, Wayne, et al.
Publicado: (2019)